TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12610676

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Risk stratification tools
Number of subjects: 0
Study: 10586152

Group type: EXPERIMENTAL
Intervention: Transparent hydrocolloid dressing
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard polyurethane dressing
Number of subjects: 132
Study: 8607501

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg twice daily plus metronidazole 250 mg four times daily
Number of subjects: 41

Group type: COMPARATOR
Intervention: Methylprednisolone 0.7 mg/kg/day with variable tapering to 40 mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin plus metronidazole
Number of subjects: 41

Group type: COMPARATOR
Intervention: Methylprednisolone
Number of subjects: 41
Study: 2012458

Group type: EXPERIMENTAL
Intervention: 24-hour nicotine delivery
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Nicotine delivery during wakeful hours only
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patches
Number of subjects: 158
Study: 6129858

Group type: EXPERIMENTAL
Intervention: Clobazam (Frisium 20) administered in the morning for 28 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clobazam (Frisium 20) administered at night for 28 days
Number of subjects: 60
Study: 30629474

Group type: EXPERIMENTAL
Intervention: Moderate-continuous training (CONT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (INT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: CONT
Number of subjects: 28

Group type: COMPARATOR
Intervention: INT
Number of subjects: 28

Group type: COMPARATOR
Intervention: Both CONT and INT
Number of subjects: 28
Study: 29460049

Group type: EXPERIMENTAL
Intervention: Blom Singer Low Pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blom Singer Classic Indwelling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Provox Vega
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patient self-evaluation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Experts' choice
Number of subjects: 0
Study: 27071768

Group type: EXPERIMENTAL
Intervention: Pramlintide 30 or 60 µg
Number of subjects: 1251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1251
Study: 24501005

Group type: EXPERIMENTAL
Intervention: LDV 90 mg QD for 24 weeks
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LDV 90 mg QD for 12 weeks
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LDV 30 mg QD for 24 weeks
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LDV 90 mg QD for 12 weeks in patients with vRVR
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LDV 90 mg QD for 24 weeks in patients with vRVR
Number of subjects: 140
Study: 21822978

Group type: EXPERIMENTAL
Intervention: Heparin plus octreotide combination treatment post-TACE
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control group (no heparin plus octreotide treatment)
Number of subjects: 147
Study: 17931721

Group type: EXPERIMENTAL
Intervention: 40,000 IU Epo
Number of subjects: 51
Study: 17150024

Group type: EXPERIMENTAL
Intervention: Natalizumab monotherapy 300 mg intravenous every 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15167852

Group type: EXPERIMENTAL
Intervention: Topical bupivacaine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 11558012

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy (LA)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Open appendectomy (OA)
Number of subjects: 43
Study: 9663954

Group type: EXPERIMENTAL
Intervention: Short muscle length (bout S)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Long muscle length (bout L)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 7
Study: 8143451

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg
Number of subjects: 2

Group type: COMPARATOR
Intervention: Progesterone 100 mg
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 3276280

Group type: EXPERIMENTAL
Intervention: Tranylcypromine (average dose, 40 mg/d)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Carbamazepine (average dose, 820 mg/d)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Trifluoperazine (average dose, 7.8 mg/d)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Alprazolam (average dose, 4.7 mg/d)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 1827023

Group type: EXPERIMENTAL
Intervention: Intravenous isradipine (0.5 mg, n = 10)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (n = 11)
Number of subjects: 21
Study: 793779

Group type: EXPERIMENTAL
Intervention: Bumetanide (1 mg to 3 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Frusemide (equipotent doses)
Number of subjects: 20
Study: 31916428

Group type: EXPERIMENTAL
Intervention: Natural extracted tooth as a coronal seal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Provisional resin preformed as a seal technique
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group 1: extraction socket left with blood clot and interrupted sutures
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group 2: extraction socket filled with BioOss Collagen and free gingival graft
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tx 1 group
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tx 2 group
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tx 3 group
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tx 4 group
Number of subjects: 12
Study: 28392215

Group type: EXPERIMENTAL
Intervention: Advanced oral hygiene care programme (AOHCP) comprising a powered toothbrush, 0.2% chlorhexidine mouthrinse, toothpaste, and oral hygiene instruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional oral hygiene care programme (COHCP) comprising a manual toothbrush, toothpaste, and oral hygiene instruction
Number of subjects: 0
Study: 25840580

Group type: EXPERIMENTAL
Intervention: Carperitide infusion
Number of subjects: 668

Group type: COMPARATOR
Intervention: Physiological saline (placebo)
Number of subjects: 668
Study: 23982402

Group type: EXPERIMENTAL
Intervention: Transportal (TP) technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Outside-in (OI) technique
Number of subjects: 80
Study: 21863207

Group type: EXPERIMENTAL
Intervention: Anxiety disorder presence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Case manager identification of anxiety disorder
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Locus of control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suicidal thinking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychotic symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Severity of substance dependence
Number of subjects: 0
Study: 19539926

Group type: EXPERIMENTAL
Intervention: rhBMP-2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 17258568

Group type: EXPERIMENTAL
Intervention: On-pump coronary artery bypass grafting
Number of subjects: 116

Group type: COMPARATOR
Intervention: Off-pump coronary artery bypass grafting
Number of subjects: 116
Study: 16287365

Group type: EXPERIMENTAL
Intervention: Runners Advantage (RA) creatine serum (5 ml containing 2.5 g of Cr)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 24
Study: 11348602

Group type: EXPERIMENTAL
Intervention: Quinapril 20 mg/day
Number of subjects: 1750
Study: 9322568

Group type: COMPARATOR
Intervention: Beta-carotene (90 mg/d for 3 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Beta-carotene (50 mg every other day for 10-12 years)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (short- and long-term)
Number of subjects: 0
Study: 7945032

Group type: EXPERIMENTAL
Intervention: Radial keratotomy
Number of subjects: 427
Study: 3224091

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31797549

Group type: EXPERIMENTAL
Intervention: Gla-300
Number of subjects: 604

Group type: COMPARATOR
Intervention: Gla-100
Number of subjects: 604
Study: 29436740

Group type: EXPERIMENTAL
Intervention: Multitarget transcranial direct current stimulation (primary motor cortex and left dorsolateral prefrontal cortex)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Primary motor cortex only
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study: 28068170

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 4501

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4501

Group type: EXPERIMENTAL
Intervention: Exemestane and Placebo (overall)
Number of subjects: 4501
Study: 26028456

Group type: EXPERIMENTAL
Intervention: SCAN intervention (nurse-led outpatient counselling, transitional guidance, routine symptom assessment, patient counselling)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: SCAN intervention
Number of subjects: 370
Study: 23981710

Group type: EXPERIMENTAL
Intervention: Staff training intervention (manualised programme comprising three phases: predisposing, enabling, and reinforcing)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 40
Study: 22176946

Group type: EXPERIMENTAL
Intervention: Visual targets
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Acoustic targets
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Antisaccade condition
Number of subjects: 31
Study: 19917951

Group type: EXPERIMENTAL
Intervention: Daily text-message reminders for 6 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: No text-message reminders
Number of subjects: 70
Study: 16314338

Group type: EXPERIMENTAL
Intervention: Implantable Loop Recorder (ILR)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Conventional investigation and management
Number of subjects: 201
Study: 15055205

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil 10 mg/day orally
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil 10 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lamivudine therapy
Number of subjects: 0
Study: 10388640

Group type: EXPERIMENTAL
Intervention: Completion angiography or angioscopy
Number of subjects: 1305

Group type: EXPERIMENTAL
Intervention: Revised defects
Number of subjects: 1305

Group type: EXPERIMENTAL
Intervention: Minor non-revised defects
Number of subjects: 1305

Group type: EXPERIMENTAL
Intervention: Technical defects
Number of subjects: 1305
Study: 8679366

Group type: EXPERIMENTAL
Intervention: Clonidine 75 micrograms
Number of subjects: 40

Group type: COMPARATOR
Intervention: Morphine 0.2 mg
Number of subjects: 40
Study: 1799473

Group type: EXPERIMENTAL
Intervention: Chlorambucil plus interferon alfa‐2b
Number of subjects: 124

Group type: COMPARATOR
Intervention: Chlorambucil alone
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2b maintenance therapy
Number of subjects: 124
Study: 6428627

Group type: EXPERIMENTAL
Intervention: Episiotomy
Number of subjects: 181

Group type: COMPARATOR
Intervention: No episiotomy
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Intact perineum
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: First degree tears
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Episiotomy after epidural anaesthesia
Number of subjects: 181
Study: 28939407

Group type: EXPERIMENTAL
Intervention: Exposure condition (playing with a colourless and odourless jelly with hands)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control condition (playing a board game)
Number of subjects: 66
Study: 26945746

Group type: EXPERIMENTAL
Intervention: HealthMap model (immediate arm)
Number of subjects: 710

Group type: COMPARATOR
Intervention: Usual care (deferred arm)
Number of subjects: 710
Study: 25548141

Group type: EXPERIMENTAL
Intervention: Candesartan (+diuretics as needed)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 180
Study: 24396959

Group type: EXPERIMENTAL
Intervention: Corneal limbal conjunctival autograft combined with pterygium excision (group A)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Pterygium excision with exposed sclera (group B)
Number of subjects: 63
Study: 20805524

Group type: EXPERIMENTAL
Intervention: Evaluation for incident AD
Number of subjects: 1695
Study: 18200040

Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0
Study: 15690319

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 23
Study: 14620246

Group type: EXPERIMENTAL
Intervention: Continuous Knowledge of Results (KR) about ball path and final location
Number of subjects: 0

Group type: COMPARATOR
Intervention: 50% KR deprivation
Number of subjects: 0

Group type: COMPARATOR
Intervention: 100% KR deprivation
Number of subjects: 0
Study: 10431100

Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with pre-coseasonal treatment
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with preseasonal treatment
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with coseasonal treatment (highest maintenance dose)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 48
Study: 9263496

Group type: EXPERIMENTAL
Intervention: Nootropil
Number of subjects: 0
Study: 2128047

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive pill (placebo week)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (unmedicated menstrual cycle)
Number of subjects: 15
Study: 375793

Group type: EXPERIMENTAL
Intervention: Hypertonic (50%) glucose
Number of subjects: 15

Group type: COMPARATOR
Intervention: Physiologic (0.9%) saline solution
Number of subjects: 15
Study: 31813404

Group type: EXPERIMENTAL
Intervention: Unsecured standing position
Number of subjects: 24

Group type: COMPARATOR
Intervention: Seated secured position
Number of subjects: 24
Study: 31375616

Group type: EXPERIMENTAL
Intervention: TV monitor advertising local current health‐related research
Number of subjects: 0
Study: 27861199

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 101
Study: 25887511

Group type: EXPERIMENTAL
Intervention: Cognitive Adaptation Training (CAT) as a nursing intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive Adaptation Training (CAT)
Number of subjects: 0
Study: 23680181

Group type: EXPERIMENTAL
Intervention: Community engagement strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early meetings with stakeholders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative study methods
Number of subjects: 0
Study: 21414216

Group type: EXPERIMENTAL
Intervention: Step Up counseling program plus usual care
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual care treatment for depression, smoking, and physical activity promotion
Number of subjects: 52
Study: 19568921

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids supplemented parenteral nutrition (0.8 g/kg/day soybean oil + 0.2 g/kg/day omega-3 FAs)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard soybean-oil based fat (1.0 g/kg/day omega-6 FAs)
Number of subjects: 56
Study: 17760535

Group type: EXPERIMENTAL
Intervention: Early-loaded dental implants (N = 18)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Delayed-loaded dental implants (N = 16)
Number of subjects: 17
Study: 15023243

Group type: EXPERIMENTAL
Intervention: Docetaxel alone (group 1A/B)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Docetaxel/trastuzumab (group 2)
Number of subjects: 52
Study: 11433055

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 350
Study: 9663944

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Penicillin-V
Number of subjects: 360

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 360
Study: 8796207

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy followed by surgery
Number of subjects: 601

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 601
Study: 2229852

Group type: EXPERIMENTAL
Intervention: Moderate exercise training (five 45‐minute sessions per week, brisk walking at 62 +/‐ 2% VO2 max for 15 weeks)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Moderate exercise training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nonexercise group
Number of subjects: 36
Study: 6107116

Group type: EXPERIMENTAL
Intervention: Clobazam 10 mg three times daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lorazepam 1 mg three times daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo 1 capsule three times daily
Number of subjects: 0
Study: 30731480

Group type: EXPERIMENTAL
Intervention: Range-of-motion exercise
Number of subjects: 36

Group type: COMPARATOR
Intervention: Tactile stimulation
Number of subjects: 36
Study: 31103126

Group type: EXPERIMENTAL
Intervention: Passive stretching (PS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Passive movement (PM)
Number of subjects: 50
Study: 28759939

Group type: EXPERIMENTAL
Intervention: Low-calorie low-carbohydrate soy containing diet
Number of subjects: 45
Study: 26254839

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23740912

Group type: EXPERIMENTAL
Intervention: Integrated basic sciences with clinical features
Number of subjects: 51

Group type: COMPARATOR
Intervention: Segregated basic sciences from clinical features
Number of subjects: 51
Study: 20606118

Group type: EXPERIMENTAL
Intervention: Aggressive decongestion (higher doses of loop diuretics, greater fluid loss)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Aggressive decongestion (hemoconcentration)
Number of subjects: 336
Study: 18284263

Group type: COMPARATOR
Intervention: Probiotics (various strains including Lactobacillus rhamnosus GG) administered for 1 or 2 months
Number of subjects: 13

Group type: COMPARATOR
Intervention: Probiotics (Lactobacillus rhamnosus GG) administered perinatally to mothers and to infants for the first 6 months
Number of subjects: 13

Group type: COMPARATOR
Intervention: L. acidophilus administered for the first 6 months of life
Number of subjects: 13

Group type: COMPARATOR
Intervention: Probiotics (various strains)
Number of subjects: 13
Study: 16815774

Group type: EXPERIMENTAL
Intervention: High fatigue condition
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Incremental fatigue
Number of subjects: 14
Study: 14738128

Group type: EXPERIMENTAL
Intervention: Brushing with a fluoridated dentifrice three times a day (B)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Application of a 2% sodium fluoride gel and exposure to the oral cavity (F)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Exposure to the oral cavity (C+)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Negative controls (C‐)
Number of subjects: 5
Study: 10946033

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg/day
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 8984570

Group type: EXPERIMENTAL
Intervention: rubber‐band ligature, anal dilator and Kamillosan ointment
Number of subjects: 120

Group type: COMPARATOR
Intervention: rubber‐band ligature alone
Number of subjects: 120

Group type: COMPARATOR
Intervention: rubber‐band ligature and anal dilator and vaseline
Number of subjects: 120
Study: 1773325

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with continuous infusion of epidural fentanyl
Number of subjects: 17

Group type: COMPARATOR
Intervention: Intermittent intramuscular morphine
Number of subjects: 17
Study: 6182833

Group type: EXPERIMENTAL
Intervention: Continuous lumbar epidural analgesia for 24 hours
Number of subjects: 38

Group type: COMPARATOR
Intervention: General anaesthesia (thiopentone‐oxygen‐nitrous oxide‐alcuronium‐pethidine sequence with artificial ventilation)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Postoperative complications combined with hypoxaemia
Number of subjects: 38

Group type: COMPARATOR
Intervention: Uneventful postoperative course
Number of subjects: 38
Study: 30822317

Group type: EXPERIMENTAL
Intervention: Attending fewer than five antenatal care (ANC) visits
Number of subjects: 1073

Group type: EXPERIMENTAL
Intervention: Prematurity
Number of subjects: 1073

Group type: EXPERIMENTAL
Intervention: Premature rupture of membranes
Number of subjects: 1073
Study: 28133725

Group type: EXPERIMENTAL
Intervention: HABIT‐ILE
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 20
Study: 25481454

Group type: EXPERIMENTAL
Intervention: Healthy School and Drugs (HSD) program
Number of subjects: 3784
Study: 23949074

Group type: EXPERIMENTAL
Intervention: Ai-Chi exercises in a swimming pool
Number of subjects: 23

Group type: COMPARATOR
Intervention: Active arm and leg exercises combined with abdominal breathing exercises at home (Control)
Number of subjects: 23
Study: 22916320

Group type: EXPERIMENTAL
Intervention: Korean Red Ginseng (KRG) 4.5 g/d for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 18443819

Group type: EXPERIMENTAL
Intervention: Strong crosstalk (attending to left-right orientation of objects)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Weak crosstalk (attending to object identity)
Number of subjects: 0
Study: 17523513

Group type: EXPERIMENTAL
Intervention: Cataract surgery with limbal relaxing incisions (LRI)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cataract surgery only (control group)
Number of subjects: 50
Study: 15968597

Group type: EXPERIMENTAL
Intervention: 131I therapy
Number of subjects: 30
Study: 11445099

Group type: EXPERIMENTAL
Intervention: IVF
Number of subjects: 415

Group type: COMPARATOR
Intervention: ICSI
Number of subjects: 415
Study: 9722035

Group type: EXPERIMENTAL
Intervention: Antithrombin III (AT III)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42